Primary Record
GSK269962A
- In stock
- 9,671 g
- Purity
- 99.4 %
- CAS
- 850664-21-0
Compound Identifiers & Properties
- CAS
- 850664-21-0
- PubChem CID
- 16095342
- SMILES
- CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6
- Canonical SMILES
- CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21
Names & Synonyms
- GSK269962A
- 850664-21-0
- GSK 269962
- GSK-269962A
- Kinome_3843
- F89KMM7TE2
- GSK 269962A
- GSK269962B
- GSK269962
- RefChem:922534
- D02ZQS
- UNII-F89KMM7TE2
- Aminofurazanyl-azabenzimidazole 6n
- GSK-269962
- MLS006010261
- GSK269962A HCl
- MFCD09970310
- ROCK inhibitor GS269962A
- C29H30N8O5
- CHEMBL220241
- GTPL8037
- orb1304125
- SCHEMBL1838346
- ROCK inhibitor GSK269962A
- SCHEMBL29365470
- SCHEMBL29387396
- BDBM14047
- DTXSID40582496
- EX-A674
- YOVNFNXUCOWYSG-UHFFFAOYSA-N
- CID 16095342
- GLXC-90467
- 925213-63-4
- BCP27824
- IVA18608
- 3703AH
- ABP000268
- DC 838
- NSC756162
- ZINC14954335
- AKOS024457925
- N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
- BCP9000742
- CS-2790
- NSC-756162
- SDCCGGSK-0000025.P001
- NCGC00241982-01
- NCGC00241982-02
- NCGC00241982-03
- NCGC00241982-09
- AC-35298
- AC-35503
- AK547999
- AS-56202
- BC600782
- BG164808
- HY-15556
- SMR004701334
- GSK269962A/GSK 269962A
- DB-230928
- GSK269962; GSK269962A
- LS-193319
- FT-0700376
- J3.437.789H
- Phenanthrene,2,7-dihydro-2,7-bis(methylene)
- A12348
- AB01092223-01
- A860055
- A863729
- Q27077891
- N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl)oxy)phenyl)-4-(2-morpholinoethoxy)benzamide
- N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(morpholin-4-yl)ethoxy]benzamide
- N0001-012971
- Benzamide, N-(3-((2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo(4,5-C)pyridin-6-yl)oxy)phenyl)-4-(2-(4-morpholinyl)ethoxy)-
- N-(3-((2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo(4,5-C)pyridin-6-yl)oxy)phenyl)-4-(2-(4-morpholinyl)ethoxy)benzamide
- N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]benzamide
- N-(3-{[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c] pyridin-6-yl]oxy}phenyl)-4-[2-(4-morpholinyl)ethoxy]benzamide
- N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-imidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholinoethoxy)benzamide
- GSK 269962A;GSK-269962A;GSK269962;GSK 269962;GSK-269962
- 168828-81-7
- 508186-08-1
- N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4, 5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]-oxy}benzamide
- N-(3-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-[2-(4-morpholinyl)ethoxy]benzamide
- N-(3-{[2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYLIMIDAZO[4,5-C]PYRIDIN-6-YL]OXY}PHENYL)-4-[2-(MORPHOLIN-4-YL)ETHOXY]BENZAMIDE
- N-(3-{[2-(4-amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy}phenyl)-4-{[2-(4-morpholinyl)ethyl]oxy}benzamide
- N-[3-[[2-(3-Amino-1,2,5-oxadiazole-4-yl)-1-ethyl-1H-imidazo[4,5-c]pyridine-6-yl]oxy]phenyl]-4-(2-morpholinoethoxy)benzamide
- N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-benzamide
- N-[3-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]benzamide; GSK 269962A; GSK269962B
- N-[3-[[2-(4-AMINOFURAZAN-3-YL)-1-ETHYL-1H-IMIDAZO[4,5-C]PYRIDIN-6-YL]OXY]PHENYL]-4-[[2-(4-MORPHOLINYL)ETHYL]OXY]BENZAMIDE
- N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
- N-{3-[2-(4-Amino-furazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yloxy]-phenyl}-4-(2-morpholin-4-yl-ethoxy)-benzamide